{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:01:01Z","timestamp":1793826061798,"version":"4.6.1"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1001\/jamaoncol.2019.4648","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T16:31:06Z","timestamp":1575563466000},"page":"227","source":"Crossref","is-referenced-by-count":47,"title":["Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era"],"prefix":"10.1001","volume":"6","author":[{"given":"Keri L.","family":"Calkins","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Chander","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"School of Medicine, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Joshu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala","family":"Visvanathan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"School of Medicine, Department of Medical Oncology, The Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Fojo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"School of Medicine, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Lesko","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"School of Medicine, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"School of Medicine, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"coi190090r1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges.","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"issue":"2","key":"coi190090r2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/aid.2016.0222","article-title":"Causes of death in HIV-infected individuals with immunovirologic success in a national prospective survey.","volume":"33","author":"Goehringer","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"coi190090r3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/apc.2014.0079","article-title":"Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.","volume":"28","author":"Schwarcz","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"10","key":"coi190090r4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/649517","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.","volume":"50","author":"Antiretroviral Therapy Cohort Collaboration","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9939","key":"coi190090r5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"coi190090r6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1089\/apc.2013.0370","article-title":"Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?","volume":"28","author":"Parameswaran","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"coi190090r7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/jac\/dku362","article-title":"Immuno-virological and clinical impacts of treating cancer in patients living with HIV.","volume":"70","author":"Le Moal","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"coi190090r8","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/DCR.0000000000000476","article-title":"HIV infection is associated with poor outcomes for patients with anal cancer in the highly active antiretroviral therapy era.","volume":"58","author":"Grew","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"coi190090r9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archsurg.133.6.626","article-title":"CD4 cell counts as a prognostic factor of major abdominal surgery in patients infected with the human immunodeficiency virus.","volume":"133","author":"Albaran","year":"1998","journal-title":"Arch Surg"},{"issue":"1","key":"coi190090r10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"coi190090r11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.biopha.2014.04.010","article-title":"Drug-drug interactions in HIV positive cancer patients.","volume":"68","author":"Flepisi","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"coi190090r12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fphar.2016.00071","article-title":"Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection.","volume":"7","author":"Berretta","year":"2016","journal-title":"Front Pharmacol"},{"issue":"12","key":"coi190090r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"coi190090r14","first-page":"678","article-title":"Lung cancer in HIV-infected patients in the combination antiretroviral treatment era.","volume":"4","author":"Molt\u00f3","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"coi190090r15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/01.JTO.0000263707.31202.d7","article-title":"Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.","volume":"2","author":"Hakimian","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"4","key":"coi190090r16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","article-title":"Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.","volume":"57","author":"Fraunholz","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"coi190090r17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3816\/CCC.2010.n.035","article-title":"Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.","volume":"9","author":"Hauerstock","year":"2010","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"coi190090r18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/QAD.0b013e3283301578","article-title":"Excellent immunological recovery following CODOX-M\/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt\u2019s lymphoma.","volume":"24","author":"Montoto","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"coi190090r19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/QAD.0000000000000133","article-title":"HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.","volume":"28","author":"Coutinho","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"coi190090r20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10549-015-3275-9","article-title":"Clinical outcomes in breast cancer patients with HIV\/AIDS: a retrospective study.","volume":"149","author":"Gomez","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"coi190090r21","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi190090r22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11908-009-0075-6","article-title":"Non\u2013AIDS-defining malignancies in patients with HIV in the HAART era.","volume":"12","author":"Nguyen","year":"2010","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"coi190090r23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrclinonc.2014.31","article-title":"Diagnosis and management of lymphomas and other cancers in HIV-infected patients.","volume":"11","author":"Carbone","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"coi190090r24","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non\u2013Hodgkin lymphomas: a pooled analysis of 1546 patients.","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"issue":"22","key":"coi190090r25","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States.","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi190090r26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamaoncol.2017.2844","article-title":"Association of HIV status with outcomes of anal squamous cell carcinoma in the era of highly active antiretroviral therapy.","volume":"4","author":"Bryant","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"coi190090r27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/QCO.0b013e3283423e0e","article-title":"Monitoring of highly active antiretroviral therapy in HIV infection.","volume":"24","author":"Walker","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"coi190090r28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection.","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"coi190090r29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/annonc\/mdr050","article-title":"Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression.","volume":"23","author":"Alfa-Wali","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"coi190090r30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/QAI.0b013e318285d934","article-title":"Prolonged decrease of CD4+ T lymphocytes in HIV-1-infected patients after radiotherapy for a solid tumor.","volume":"62","author":"Sankatsing","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"coi190090r31","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.ejca.2011.06.036","article-title":"Colorectal cancer in HIV positive individuals: the immunological effects of treatment.","volume":"47","author":"Alfa-Wali","year":"2011","journal-title":"Eur J Cancer"},{"issue":"3","key":"coi190090r32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s15010-005-4099-z","article-title":"Treatment of HIV-1\u2013associated Kaposi\u2019s sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.","volume":"33","author":"Lichterfeld","year":"2005","journal-title":"Infection"},{"issue":"21","key":"coi190090r33","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States.","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"coi190090r34","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1097\/00042560-199801001-00011","article-title":"Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV Clinical Practice Cohort.","volume":"17","author":"Moore","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"12","key":"coi190090r37","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archsurg.141.12.1238","article-title":"Surgical outcomes in human immunodeficiency virus\u2013infected patients in the era of highly active antiretroviral therapy.","volume":"141","author":"Horberg","year":"2006","journal-title":"Arch Surg"},{"issue":"9","key":"coi190090r38","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1182\/blood.V90.9.3789","article-title":"Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells.","volume":"90","author":"Hakim","year":"1997","journal-title":"Blood"},{"issue":"18","key":"coi190090r46","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/(ISSN)1097-0258","article-title":"A comparison of smoothing techniques for CD4 data measured with error in a time-dependent Cox proportional hazards model.","volume":"17","author":"Bycott","year":"1998","journal-title":"Stat Med"},{"issue":"7","key":"coi190090r47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v072.i07","article-title":"The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC.","volume":"72","author":"Rizopoulos","year":"2016","journal-title":"J Stat Softw"},{"issue":"12","key":"coi190090r48","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/sim.v30.12","article-title":"A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time-to-event.","volume":"30","author":"Rizopoulos","year":"2011","journal-title":"Stat Med"},{"issue":"10","key":"coi190090r51","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1182\/blood.V89.10.3700","article-title":"Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.","volume":"89","author":"Mackall","year":"1997","journal-title":"Blood"},{"issue":"6","key":"coi190090r52","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/095530099140113","article-title":"Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy.","volume":"75","author":"Louagie","year":"1999","journal-title":"Int J Radiat Biol"},{"issue":"10","key":"coi190090r53","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/0959-8049(92)90079-H","article-title":"Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of \u201cnaive\u201d (CD4-CD45R) T lymphocytes.","volume":"28A","author":"De Ruysscher","year":"1992","journal-title":"Eur J Cancer"},{"issue":"2","key":"coi190090r54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.132.2.1026","article-title":"Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin\u2019s disease.","volume":"132","author":"Haas","year":"1984","journal-title":"J Immunol"},{"issue":"10","key":"coi190090r55","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2169\/internalmedicine.34.959","article-title":"Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients.","volume":"34","author":"Nakayama","year":"1995","journal-title":"Intern Med"},{"issue":"2","key":"coi190090r56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1148\/radiology.168.2.3260678","article-title":"Changes in T-cell subsets after radiation therapy.","volume":"168","author":"Yang","year":"1988","journal-title":"Radiology"},{"issue":"7","key":"coi190090r57","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10350-004-6677-z","article-title":"Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer.","volume":"46","author":"Wichmann","year":"2003","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"coi190090r58","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/2141-9248.122054","article-title":"Pattern of CD4 T-lymphocyte values in cancer patients on cytotoxic therapy.","volume":"3","author":"Madu","year":"2013","journal-title":"Ann Med Health Sci Res"},{"issue":"10","key":"coi190090r59","doi-asserted-by":"publisher","first-page":"O672","DOI":"10.1111\/1469-0691.12589","article-title":"Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.","volume":"20","author":"Torres","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"coi190090r60","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/CCO.0b013e32832f3e04","article-title":"Targeted therapies to treat non\u2013AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook.","volume":"21","author":"Deeken","year":"2009","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"coi190090r61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003088-200544020-00001","article-title":"Interactions between antiretrovirals and antineoplastic drug therapy.","volume":"44","author":"Antoniou","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"coi190090r62","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1200\/JOP.2014.002709","article-title":"Cancer treatment in patients with HIV infection and non\u2013AIDS-defining cancers: a survey of US oncologists.","volume":"11","author":"Suneja","year":"2015","journal-title":"J Oncol Pract"},{"key":"coi190090r45","doi-asserted-by":"crossref","DOI":"10.1201\/9781420011579","volume-title":"Longitudinal Data Analysis","author":"Fitzmaurice","year":"2008"},{"key":"coi190090r49","doi-asserted-by":"crossref","DOI":"10.1201\/b12208","volume-title":"Joint Models for Longitudinal and Time-to-Event Data: With Applications in R","author":"Rizopoulos","year":"2012"},{"key":"coi190090r50","author":"R Core Team","year":"2017"},{"key":"coi190090r35","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. ICD-O-3\/WHO 2008 Definition. https:\/\/seer.cancer.gov\/siterecode\/icdo3_dwhoheme\/index.html. Updated January 20, 2017. Accessed September 14, 2017."},{"key":"coi190090r36","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Summary Staging Manual\u20132000 Codes and Coding Instructions. https:\/\/seer.cancer.gov\/tools\/ssm\/ssm2000\/SSSM2000-122012.pdf. Updated December 2012. Accessed September 14, 2017."},{"key":"coi190090r39","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Statistics Review (CSR) 1975-2014 SEER Statistics. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2014\/. Updated April 2, 2018. Accessed February 28, 2018."},{"key":"coi190090r40","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Small Intestine Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/smint.html. Updated January 20, 2017. Accessed February 28, 2018."},{"key":"coi190090r41","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Anal Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/anus.html. Updated January 20, 2017. Accessed February 28, 2018."},{"key":"coi190090r42","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Vulvar Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html. Updated January 18, 2017. Accessed February 28, 2018."},{"key":"coi190090r43","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Query Systems. https:\/\/seer.cancer.gov\/canques\/index.html. Updated September 27, 2016. Accessed February 28, 2018."},{"key":"coi190090r44","unstructured":"American Cancer Society. Survival Rates for Penile Cancer. https:\/\/www.cancer.org\/cancer\/penile-cancer\/detection-diagnosis-staging\/survival-rates.html. Published August 3, 2017. Accessed February 28, 2018."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2757078\/jamaoncology_calkins_2019_oi_190090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:53:23Z","timestamp":1695491603000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2757078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.4648","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}